The landscape of dementia analysis has progressed radically with the advent of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-centered tests that may detect Alzheimer's pathology several years before signs arise. While these technological improvements characterize outstanding progress in knowledge neurodegenerative diseases, they